English | Español
Carrice Quinnie | Jun 4, 2017

Merck enters exclusive license agreement with Teijin Pharma
Robert Hadley | Jun 4, 2017

AstraZeneca to reveal results of three cancer-fighting drugs at ASCO meeting
Robert Hadley | Jun 4, 2017

Merck’s targeted tumor drug approved for colorectal and other cancers
Robert Hadley | Jun 3, 2017

FDA OKs Novartis' Zykadia for metastatic lung cancer affecting the brain
Robert Hadley | Jun 2, 2017

FDA approves higher once-a-day dose of Merck’s Isentress HIV drug 
Tabitha Fleming | Jun 2, 2017

Merck's Keytruda approved for treating Hodgkin's lymphoma in Europe
Robert Hadley | May 31, 2017

FDA greenlights review of Bristol-Myers Squibb’s Opdivo for liver cancer
John Breslin | May 31, 2017

Senators push bill to make medically necessary foods eligible for insurance coverage

Trending
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Regulatory
Patient Daily | May 12, 2025

Turning Point USA founder: 'Big pharma’s lobbying of Washington DC has long allowed them to price gouge Americans'